Full Text View
Tabular View
No Study Results Posted
Related Studies
Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.
This study is currently recruiting participants.
Verified May 2013 by University of North Carolina, Chapel Hill
Study NCT01320293   Information provided by University of North Carolina, Chapel Hill

First Received on March 18, 2011.   Last Updated on May 13, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
Adalimumab
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antirheumatic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of North Carolina, Chapel Hill
AbbVie


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services